幽门螺杆菌感染动态作为胃癌前病变进展的决定因素:根除试验16年随访
795例胃癌前病变成人基线随机接受抗幽门螺杆菌治疗,随访16年时456人受检。持续感染16年者进展为更高级别诊断的概率高于根除后持续阴性者(p=0.001);不完全型肠化生进展为癌的风险高于完全型(OR 11.3,95%CI 1.4至91.4)。
要点
- 持续感染幽门螺杆菌16年者病变进展概率高于根除后持续阴性者(p=0.001)。
- 不完全型肠化生进展为癌风险高于完全型(OR 11.3,95%CI 1.4至91.4)。
- 持续感染者组织病理学评分平均每年增加0.20单位(95%CI 0.12至0.28)。
核心结论
- 长期暴露于幽门螺杆菌感染与胃癌前病变进展相关。
- 感染幽门螺杆菌并伴这些病变的个体可能从根除中获益,尤其伴有无肠化生的萎缩性胃炎者。
- 不完全型肠化生可能是识别癌风险较高个体的有用标志物。
研究设计与样本
- 795例伴有胃癌前病变的成人基线随机接受抗幽门螺杆菌治疗。
- 基线及第3、6、12、16年采集胃活检,共456人参加16年访视。
- 幽门螺杆菌累积暴露时间按随访期间感染年数计算,采用多变量logistic回归模型评估进展风险。
主要发现
- 持续感染幽门螺杆菌16年者进展为更高级别诊断的概率高于基线后根除并持续阴性者(p=0.001)。
- 不完全型肠化生进展为癌的风险高于完全型(OR 11.3,95%CI 1.4至91.4)。
- 持续感染幽门螺杆菌者组织病理学评分平均每年增加0.20单位(95%CI 0.12至0.28)。
- 累积感染时间对组织病理学评分进展的影响在萎缩(无肠化生)者中显著高于肠化生者(p<0.001)。
关键数值与推荐
- 进展定义为进展为更高级别诊断(相对于无变化或消退)。
- 组织病理学评分评估病变严重程度与范围(范围1-6),基线至16年的评分差值采用广义线性模型建模。
- 不完全型肠化生进展为癌的OR为11.3(95%CI 1.4至91.4)。
- 持续感染者组织病理学评分平均每年增加0.20单位(95%CI 0.12至0.28)。
临床怎么用
- 作者认为感染幽门螺杆菌并伴胃癌前病变的个体可能从根除中获益,尤其伴无肠化生的萎缩性胃炎者。
- 作者认为不完全型肠化生可能是识别癌风险较高个体的有用标志物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the long-term effect of cumulative time exposed to Helicobacter pylori infection on the progression of gastric lesions. DESIGN: 795 adults with precancerous gastric lesions were randomised to receive anti-H. pylori treatment at baseline. Gastric biopsies were obtained at baseline and at 3, 6, 12 and 16 years. A total of 456 individuals attended the 16-year visit. Cumulative time of H. pylori exposure was calculated as the number of years infected during follow-up. Multivariable logistic regression models were used to estimate the risk of progression to a more advanced diagnosis (versus no change/regression) as well as gastric cancer risk by intestinal metaplasia (IM) subtype. For a more detailed analysis of progression, we also used a histopathology score assessing both severity and extension of the gastric lesions (range 1-6). The score difference between baseline and 16 years was modelled by generalised linear models. RESULTS: Individuals who were continuously infected with H. pylori for 16 years had a higher probability of progression to a more advanced diagnosis than those who cleared the infection and remained negative after baseline (p=0.001). Incomplete-type IM was associated with higher risk of progression to cancer than complete-type (OR, 11.3; 95% CI 1.4 to 91.4). The average histopathology score increased by 0.20 units/year (95% CI 0.12 to 0.28) among individuals continuously infected with H. pylori. The effect of cumulative time of infection on progression in the histopathology score was significantly higher for individuals with atrophy (without IM) than for individuals with IM (p<0.001). CONCLUSIONS: Long-term exposure to H. pylori infection was associated with progression of precancerous lesions. Individuals infected with H. pylori with these lesions may benefit from eradication, particularly those with atrophic gastritis without IM. Incomplete-type IM may be a useful marker for the identification of individuals at higher risk for cancer.
引用
- Mera RM, Bravo LE, Camargo MC, et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2017. PMID: 28647684. doi:10.1136/gutjnl-2016-311685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。